Skip to main content

Table 5 Mean homocysteine, red cell folate and vitamin B12 concentration at baseline and follow up according to treatment group

From: The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial

 

Baseline: mean (standard deviation)

Follow-up: mean (standard deviation)

Difference (95% confidence interval)

P-value (paired t-test)

Homocysteine (micromol/L)

    

Placebo (n = 463)

13.4 (5.0)

14.3 (5.7)

0.88 (0.40,1.36)

<0.001

B-Vitamins (n = 462)

13.5 (6.3)

10.5 (4.2)

−3.06 (−3.53,-2.59)

<0.001

Red cell Folate (nmol/L)

    

Placebo (n = 173)

895.0 (466.6)

1135.2 (666.8)

244.8 (151.0,338.7)

<0.001

B-Vitamins (n = 183)

959.2 (464.1)

2181.5 (752.3)

1220.0 (1117,1341)

<0.001

B 12 (pmol/L)

    

Placebo (n = 190)

317.6 (140.8)

315.3 (188.9)

−2.3 (−26.4,31.1)

0.87

B-Vitamins (n – 196)

322.1 (150.8)

594.7 (271.9)

272.6 (235.2,310.0)

<0.001

  1. Note: Only small subsets of patients had homocysteine, folate and vitamin B12 measured at both baseline and follow up.